Diabetes Care, Vol 20, Issue 10 1562-1568, Copyright © 1997 by American Diabetes Association

ARTICLES

Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects

K Matsumoto, S Miyake, M Yano, Y Ueki, Y Yamaguchi, S Akazawa and Y Tominaga
Department of Internal Medicine, Sasebo Chuou Hospital, Sasebo City, Japan.

OBJECTIVE: To investigate the relative contributions of insulin secretion and insulin resistance to the development of glucose intolerance in Japanese subjects. RESEARCH DESIGN AND METHODS: A cross-sectional study of 756 Japanese subjects (530 nonobese, 226 obese) was performed. A 75-g oral glucose tolerance test (OGTT) was given, and subjects were classified according to the World Health Organization (WHO) criteria (normal glucose tolerance [NGT], impaired glucose tolerance [IGT], and diabetes). Early-phase insulin secretion was assessed by the insulinogenic index (the ratio of the increment of insulin to that of plasma glucose [PG] 30 min after a glucose load [delta IRI0-30 min/delta PG0-30 min]). Total insulin secretion was assessed by mean immunoreactive insulin (IRI) during the OGTT, and insulin resistance was assessed by use of the homeostasis model [HOMA(R)]. RESULTS: Early-phase insulin secretion was significantly decreased in IGT, compared with patients with NGT, in both the nonobese and obese subjects (0.70 +/- 0.05 vs. 0.37 +/- 0.03, P < 0.01 and 1.36 +/- 0.19 vs. 0.73 +/- 0.08, P < 0.01, respectively). However, mean IRI and HOMA(R) in both nonobese and obese subjects with IGT and NGT were not statistically different. Subjects with diabetes showed a significant decline in early-phase and total insulin secretion and a significantly higher level of insulin resistance than did subjects with IGT. When the fasting glucose (FPG) exceeded 100 mg/dl, early-phase insulin decreased progressively. The graphed relationship between FPG and mean IRI did not show an inverted U-shape, and mean IRI decreased progressively when FPG exceeded 100-130 mg/dl. The pattern of changes in insulin secretion and insulin resistance associated with the progression of glucose intolerance was similar in both the nonobese and obese subjects. CONCLUSIONS: The worsening from NGT to IGT in Japanese subjects may be associated with a decrease in early-phase insulin secretion in nonobese as well as in obese subjects. Hyperinsulinemia in IGT is not common. We suggest that impaired early-phase insulin secretion may be the initial abnormality in the development of glucose intolerance in Japanese people. Insulin resistance may be a consequence of hyperglycemia and/or obesity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. A. McAuley, J. I. Mann, J. G. Chase, T. F. Lotz, and G. M. Shaw Point: HOMA Satisfactory for the Time Being: HOMA: The best bet for the simple determination of insulin sensitivity, until something better comes along Diabetes Care, September 1, 2007; 30(9): 2411 - 2413. [Full Text] [PDF]

				Y. Song, J. E. Manson, L. Tinker, B. V. Howard, L. H. Kuller, L. Nathan, N. Rifai, and S. Liu Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women: The Women's Health Initiative Observational Study Diabetes Care, July 1, 2007; 30(7): 1747 - 1752. [Abstract] [Full Text] [PDF]

				N. Rasouli, P. A Kern, E. A. Reece, and S. C. Elbein Effects of pioglitazone and metformin on beta-cell function in nondiabetic subjects at high risk for type 2 diabetes Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E359 - E365. [Abstract] [Full Text] [PDF]

				N. Takashima, H. Tomoike, N. Iwai, C. Erikstrup, O. H. Mortensen, B. K. Pedersen, J. Oh, T. E. Graham, U. Smith, and B. B. Kahn Retinol-Binding Protein 4 and Insulin Resistance. N. Engl. J. Med., September 28, 2006; 355(13): 1392 - 1395. [Full Text] [PDF]

				A. V. Matveyenko, J. D. Veldhuis, and P. C. Butler Mechanisms of impaired fasting glucose and glucose intolerance induced by a ~50% pancreatectomy. Diabetes, August 1, 2006; 55(8): 2347 - 2356. [Abstract] [Full Text] [PDF]

				T. M. Wallace, J. C. Levy, and D. R. Matthews Use and Abuse of HOMA Modeling Diabetes Care, June 1, 2004; 27(6): 1487 - 1495. [Abstract] [Full Text] [PDF]

				M. Sasahara, M. Nishi, H. Kawashima, K. Ueda, S. Sakagashira, H. Furuta, E. Matsumoto, T. Hanabusa, H. Sasaki, and K. Nanjo Uncoupling Protein 2 Promoter Polymorphism -866G/A Affects Its Expression in {beta}-Cells and Modulates Clinical Profiles of Japanese Type 2 Diabetic Patients Diabetes, February 1, 2004; 53(2): 482 - 485. [Abstract] [Full Text]

				M. Maliqueo, I. Atwater, R. Lahsen, F. Perez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of {beta}-cell dysfunction? Hum. Reprod., December 1, 2003; 18(12): 2683 - 2688. [Abstract] [Full Text] [PDF]

				H. Suzuki, M. Fukushima, M. Usami, M. Ikeda, A. Taniguchi, Y. Nakai, T. Matsuura, A. Kuroe, K. Yasuda, T. Kurose, et al. Factors Responsible for Development From Normal Glucose Tolerance to Isolated Postchallenge Hyperglycemia Diabetes Care, April 1, 2003; 26(4): 1211 - 1215. [Abstract] [Full Text] [PDF]

				H. Nagaretani, T. Nakamura, T. Funahashi, K. Kotani, M. Miyanaga, K. Tokunaga, M. Takahashi, H. Nishizawa, K. Kishida, H. Kuriyama, et al. Visceral Fat Is a Major Contributor for Multiple Risk Factor Clustering in Japanese Men With Impaired Glucose Tolerance Diabetes Care, December 1, 2001; 24(12): 2127 - 2133. [Abstract] [Full Text] [PDF]

				N. M. Wedick, E. J. Mayer-Davis, D. L. Wingard, C. L. Addy, and E. Barrett-Connor Insulin Resistance Precedes Weight Loss in Adults without Diabetes : The Rancho Bernardo Study Am. J. Epidemiol., June 15, 2001; 153(12): 1199 - 1205. [Abstract] [Full Text] [PDF]